Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 2 June 2021
Kuros Biosciences’s commercial roll-out of MagnetOs bone graft exceeds expectations
Press Release, 17 May 2021
Kuros to receive $4 million milestone payment from Checkmate Pharmaceuticals
Press Release, 5 May 2021
Kuros Biosciences strengthens its patent position on use of Fibrin-PTH in spinal fusion
Press Release, 19 April 2021
Annual General Meeting of Kuros Biosciences approves majority of resolutions
Press Release, 13 April 2021
Kuros Biosciences treats first patient in clinical trial of MagnetOs Putty for posterolateral spine fusion
Press Release, 8 April 2021
Kuros Biosciences announces treatment of first patient in Australia with MagnetOs for spine fusion